Evaluation of HER2 Targeted Poly(Ethylene Glycol)‐Poly( L ‐histidine) Copolymer Micelles in Breast Cancer Models
Macromolecular Bioscience · 2025
DOI: 10.1002/mabi.202500047 ↗Kurz gefasst
Fachartikel in der Zeitschrift Macromolecular Bioscience, 2025. Verfasst von Remya Valsala Kumari und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Tumor Biology, Institute For Cancer Research, Oslo University Hospital, Oslo, Norway. Hauptthemen laut MEDLINE: Micelles, Erb-b2 Receptor Tyrosine Kinases, Polyethylene Glycols, Histidine. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: EEA NORWAY, Ministry of Research, Innovation and Digitization, CNCS/CCCDI-UEFISCDI.
Abstract (Originalsprache)
Breast cancer positive for human epidermal growth factor receptor‐2 (HER2) is challenging to treat due to the development of drug resistance, even with recently developed antibody‐mediated therapeutics. However, nanotechnology provides new innovative therapeutic strategies. This study evaluates the efficacy of new HER2‐targeted, pH‐sensitive poly(ethylene glycol)‐poly(L‐histidine) copolymer micelles (PEG‐PHis micelles), either empty, loaded with the drug doxorubicin (DOX), or the fluorophore Rhodamine‐B (RB) for imaging purposes. Cellular association of the micelles, in vitro effects on proliferation and cytotoxicity, as well as ex vivo and in vivo responses on tumor growth are assessed. The results indicate that trastuzumab (TZM) conjugation enhances the specific cellular association of PEG‐PHis micelles in HER2 overexpressing cells and improves the cytotoxic effects of the micelles themselves. Although the TZM conjugation of DOX‐loaded micelles did not contribute to an enhancement in overall efficacy in cell lines and tumor explant cultures, the findings highlight the potential of TZM conjugation on these micelles in targeting HER2‐positive tumors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Tumor Biology, Institute For Cancer Research, Oslo University Hospital, Oslo, Norway.
- Department of Molecular Cell Biology, Institute For Cancer Research, Oslo University Hospital, Oslo, Norway.
- Centre For Cancer Cell Reprogramming, University of Oslo, Oslo, Norway.
- Centre of Advanced Research in Bionanoconjugates and Biopolymers, "Petru Poni" Institute of Macromolecular Chemistry, Iasi, Romania.
- Regional Institute of Oncology, Iasi, Romania.
- University of Medicine and Pharmacy "Grigore T. Popa", Iasi, Romania.
ORCID-Profile: Remya Valsala Kumari, Abhilash D Pandya, Solveig J Pettersen, Audun Kvalvaag, Razvan Ghiarasim, Alexandru Rotaru, Tore Skotland, Kirsten Sandvig, Gunhild Mari Mælandsmo, Tore-Geir Iversen
Förderung
- EEA NORWAY
- Ministry of Research, Innovation and Digitization
- CNCS/CCCDI-UEFISCDI
Zitieren
APA
Valsala Kumari, R., Pandya, A. D., Pettersen, S. J., Kvalvaag, A., Myrann, A. G., Ghiarasim, R., Rotaru, A., Dimofte, M. G., Skotland, T., Sandvig, K., Mari Mælandsmo, G., & Iversen, T. G. (2025). Evaluation of HER2 Targeted Poly(Ethylene Glycol)‐Poly( L ‐histidine) Copolymer Micelles in Breast Cancer Models. Macromolecular Bioscience. https://doi.org/10.1002/mabi.202500047
Vancouver
Valsala Kumari R, Pandya AD, Pettersen SJ, Kvalvaag A, Myrann AG, Ghiarasim R, et al. Evaluation of HER2 Targeted Poly(Ethylene Glycol)‐Poly( L ‐histidine) Copolymer Micelles in Breast Cancer Models. Macromolecular Bioscience. 2025. doi:10.1002/mabi.202500047
BibTeX
@article{ValsalaKumari2025,
author = {Valsala Kumari, Remya and Pandya, Abhilash D and Pettersen, Solveig J and Kvalvaag, Audun and Myrann, Anne Grethe and Ghiarasim, Razvan and Rotaru, Alexandru and Dimofte, Mihail-Gabriel and Skotland, Tore and Sandvig, Kirsten and Mari Mælandsmo, Gunhild and Iversen, Tore-Geir},
title = {Evaluation of HER2 Targeted Poly(Ethylene Glycol)‐Poly( L ‐histidine) Copolymer Micelles in Breast Cancer Models},
journal = {Macromolecular Bioscience},
year = {2025},
doi = {10.1002/mabi.202500047}
}
EUVIMED